Leidos is in a pronounced downtrend over the past year, with the stock down 22.48% over the last 12 months, significantly underperforming the S&P 500's +21.46% gain. The current price of $135.26 sits at 65.7% of its 52-week range (between $98.86 low and $205.77 high), indicating the stock is closer to its lows than highs, reflecting a bearish sentiment and potential value trap. The 52-week low of $98.86 was tested in late June, and the stock has since bounced, but it remains well below its 52-week high of $205.77, suggesting a lack of buying conviction.

Leidos reported Q1 2026 revenue of $4.40 billion, up 3.65% year-over-year, but this was a deceleration from the prior quarter's 4.5% growth and below expectations, contributing to the stock's decline. The company's net income for Q1 was $328 million, with a net margin of 7.45%, down from 8.21% in Q3 2025, indicating slight margin compression. Gross margin improved to 17.3% from 16.0% in Q4 2025, but operating margin fell to 11.5% from 12.0% in Q4, reflecting increased operating expenses. The company's balance sheet shows a debt-to-equity ratio of 1.21, which is elevated but manageable given its strong free cash flow of $1.859 billion TTM. However, Q1 2026 free cash flow was only $270 million, a significant drop from $452 million in Q4 2025, due to a $2.34 billion acquisition, which increased leverage and reduced liquidity.